Does TREPROSTINIL Cause Covid-19 pneumonia? 147 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 147 reports of Covid-19 pneumonia have been filed in association with TREPROSTINIL (TYVASO). This represents 0.2% of all adverse event reports for TREPROSTINIL.
147
Reports of Covid-19 pneumonia with TREPROSTINIL
0.2%
of all TREPROSTINIL reports
23
Deaths
141
Hospitalizations
How Dangerous Is Covid-19 pneumonia From TREPROSTINIL?
Of the 147 reports, 23 (15.6%) resulted in death, 141 (95.9%) required hospitalization, and 10 (6.8%) were considered life-threatening.
Is Covid-19 pneumonia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TREPROSTINIL. However, 147 reports have been filed with the FAERS database.
What Other Side Effects Does TREPROSTINIL Cause?
Dyspnoea (16,348)
Headache (14,051)
Diarrhoea (11,335)
Nausea (10,320)
Cough (8,945)
Fatigue (7,440)
Dizziness (7,405)
Infusion site pain (5,169)
Vomiting (5,097)
Death (4,764)
What Other Drugs Cause Covid-19 pneumonia?
RITUXIMAB (1,489)
DEXAMETHASONE (758)
LENALIDOMIDE (750)
PREDNISONE (749)
OCRELIZUMAB (669)
TACROLIMUS (622)
MYCOPHENOLATE MOFETIL (594)
PREDNISOLONE (479)
METHOTREXATE (472)
CYCLOPHOSPHAMIDE (430)
Which TREPROSTINIL Alternatives Have Lower Covid-19 pneumonia Risk?
TREPROSTINIL vs TREPROSTINIL DIOLAMINE
TREPROSTINIL vs TRETINOIN
TREPROSTINIL vs TRIAMCINOLONE
TREPROSTINIL vs TRIAMCINOLONE ACETONIDE
TREPROSTINIL vs TRIAMCINOLONE HEXACETONIDE